Inj enfort vedo-ejfv 0.25mg
Products billed under this code include Padcev.
Payment limit per 0.25 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Padcev.
Payment limit per 0.25 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Padcev | Pfizer Inc | 51144-0020-01 | 80 | $2,922.80 |
| Padcev | Pfizer Inc | 51144-0030-01 | 120 | $4,384.20 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $36.535 | −$0.123 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted September 17, 2026 |
| 3Q26 | $36.658 | −$0.049 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted September 15, 2026 |
| 2Q26 | $36.707 | −$0.011 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted September 15, 2026 |
| 1Q26 | $36.718 | −$0.025 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted September 15, 2026 |
| 4Q25 | $36.743 | +$0.08 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted September 8, 2026 |
| 3Q25 | $36.663 | +$0.021 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted March 10, 2026 |
| 2Q25 | $36.642 | −$0.005 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted March 10, 2026 |
| 1Q25 | $36.647 | −$0.094 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted December 19, 2025 |
| 4Q24 | $36.741 | +$0.624 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted June 11, 2025 |
| 3Q24 | $36.117 | −$0.084 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted June 11, 2025 |
| 2Q24 | $36.201 | +$1.173 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted March 11, 2025 |
| 1Q24 | $35.028 | −$0.029 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted December 19, 2024 |
| 4Q23 | $35.057 | +$1.239 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted October 10, 2024 |
| 3Q23 | $33.818 | +$0.005 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted June 5, 2024 |
| 2Q23 | $33.813 | +$1.243 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted February 23, 2024 |
| 1Q23 | $32.57 | +$0.016 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted December 6, 2023 |
| 4Q22 | $32.554 | +$1.198 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted June 22, 2023 |
| 3Q22 | $31.356 | +$0.02 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted June 9, 2023 |
| 2Q22 | $31.336 | +$1.15 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted December 14, 2022 |
| 1Q22 | $30.186 | +$0.016 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted June 8, 2022 |
| 4Q21 | $30.17 | +$1.107 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted June 2, 2022 |
| 3Q21 | $29.063 | +$0.019 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted June 2, 2022 |
| 2Q21 | $29.044 | +$1.086 | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted March 1, 2022 |
| 1Q21 | $27.958 | – | 0.25 MG | Inj enfort vedo-ejfv 0.25mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.